Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation

Wilms' tumor gene 1 (WT1) is overexpressed in leukemia and WT1-derived CD8+ T-cell epitopes for immunotherapies targeting WT1 have been defined. Here, we analyzed expression of WT1 in 226 peripheral blood and bone marrow samples from patients with acute myeloid leukemia or myelodysplastic syndr...

Full description

Saved in:
Bibliographic Details
Main Authors: Casalegno Garduño, Rosaely (Author) , Schmitt, Anita (Author) , Spitschak, Alf (Author) , Greiner, Jochen (Author) , Wang, Lei (Author) , Hilgendorf, Inken (Author) , Hirt, Carsten (Author) , Ho, Anthony Dick (Author) , Freund, Mathias (Author) , Schmitt, Michael (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: International journal of cancer
Year: 2015, Volume: 138, Issue: 7, Pages: 1792-1801
ISSN:1097-0215
DOI:10.1002/ijc.29909
Online Access:Verlag, Volltext: https://doi.org/10.1002/ijc.29909
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.29909
Get full text
Author Notes:Rosaely Casalegno‐Garduño, Anita Schmitt, Alf Spitschak, Jochen Greiner, Lei Wang, Inken Hilgendorf, Carsten Hirt, Anthony D. Ho, Mathias Freund and Michael Schmitt

MARC

LEADER 00000caa a2200000 c 4500
001 1689992824
003 DE-627
005 20250322011429.0
007 cr uuu---uuuuu
008 200213r20162015xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.29909  |2 doi 
035 |a (DE-627)1689992824 
035 |a (DE-599)KXP1689992824 
035 |a (OCoLC)1341305346 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Casalegno Garduño, Rosaely  |d 1982-  |e VerfasserIn  |0 (DE-588)1025918991  |0 (DE-627)72557111X  |0 (DE-576)370910443  |4 aut 
245 1 0 |a Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation  |c Rosaely Casalegno‐Garduño, Anita Schmitt, Alf Spitschak, Jochen Greiner, Lei Wang, Inken Hilgendorf, Carsten Hirt, Anthony D. Ho, Mathias Freund and Michael Schmitt 
264 1 |c 2016 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online 31 October 2015 
500 |a Gesehen am 13.02.2020 
520 |a Wilms' tumor gene 1 (WT1) is overexpressed in leukemia and WT1-derived CD8+ T-cell epitopes for immunotherapies targeting WT1 have been defined. Here, we analyzed expression of WT1 in 226 peripheral blood and bone marrow samples from patients with acute myeloid leukemia or myelodysplastic syndrome (AML/MDS) before and after allogeneic stem cell transplantation (SCT). Transcripts were assessed by quantitative polymerase chain reaction, and WT1-specific CD8+ cytotoxic T cells (CTL) were monitored by tetramer staining and enzyme-linked immunospot (ELISPOT) assays. Reduction of WT1 levels correlated with a longer survival (p < 0.01). Increment of WT1 transcripts eventually resulted in relapse and subsequent death of the patients. In patients with longer survival and continuous complete remission (cCR) after SCT, higher and enduring frequencies of WT1-specific CTL than in patients developing a relapse were detected. These cells were effector T cells secreting interferon gamma and granzyme B. In summary, WT1 is a suitable marker for the detection of minimal residual disease after SCT or chemotherapy. A rising WT1 signal correlated with a dismal prognosis of the patients. WT1-specific CD8+ T cells might contribute to the maintenance of a cCR. Targeting WT-1 by peptide/protein vaccination as well as adoptive transfer of genetically modified T cells are future options in the individualized therapy for AML/MDS patients. 
534 |c 2015 
650 4 |a AML 
650 4 |a MDS 
650 4 |a specific T cells 
650 4 |a WT1 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
700 1 |a Spitschak, Alf  |e VerfasserIn  |4 aut 
700 1 |a Greiner, Jochen  |e VerfasserIn  |4 aut 
700 1 |a Wang, Lei  |d 1985-  |e VerfasserIn  |0 (DE-588)1076031994  |0 (DE-627)834093308  |0 (DE-576)444802398  |4 aut 
700 1 |a Hilgendorf, Inken  |e VerfasserIn  |4 aut 
700 1 |a Hirt, Carsten  |e VerfasserIn  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |8 1\p  |a Freund, Mathias  |d 1949-2023  |e VerfasserIn  |0 (DE-588)108837785  |0 (DE-627)582062217  |0 (DE-576)289623448  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 138(2016), 7, Seite 1792-1801  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation 
773 1 8 |g volume:138  |g year:2016  |g number:7  |g pages:1792-1801  |g extent:10  |a Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation 
856 4 0 |u https://doi.org/10.1002/ijc.29909  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.29909  |x Verlag  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250301  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20200213 
993 |a Article 
994 |a 2016 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 10  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/ 
998 |g 1076031994  |a Wang, Lei  |m 1076031994:Wang, Lei  |d 910000  |d 910100  |e 910000PW1076031994  |e 910100PW1076031994  |k 0/910000/  |k 1/910000/910100/ 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |e 910000PS141722495  |e 910100PS141722495  |k 0/910000/  |k 1/910000/910100/ 
998 |g 1025918991  |a Casalegno Garduño, Rosaely  |m 1025918991:Casalegno Garduño, Rosaely  |d 910000  |d 910100  |e 910000PC1025918991  |e 910100PC1025918991  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1689992824  |e 3594847632 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1689992824"],"doi":["10.1002/ijc.29909"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"title":[{"title_sort":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title":"International journal of cancer"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"corporate":[{"display":"International Union against Cancer","role":"isb"}],"origin":[{"dateIssuedDisp":"1966-","publisher":"Wiley-Liss","publisherPlace":"Bognor Regis","dateIssuedKey":"1966"}],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"part":{"text":"138(2016), 7, Seite 1792-1801","volume":"138","year":"2016","pages":"1792-1801","extent":"10","issue":"7"},"id":{"doi":["10.1002/(ISSN)1097-0215"],"issn":["1097-0215"],"zdb":["1474822-8"],"eki":["269532781"]},"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"Predictive oncology"}],"language":["eng"],"disp":"Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantationInternational journal of cancer","recId":"269532781","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1966 -"]}],"note":["Online 31 October 2015","Gesehen am 13.02.2020"],"recId":"1689992824","name":{"displayForm":["Rosaely Casalegno‐Garduño, Anita Schmitt, Alf Spitschak, Jochen Greiner, Lei Wang, Inken Hilgendorf, Carsten Hirt, Anthony D. Ho, Mathias Freund and Michael Schmitt"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"person":[{"given":"Rosaely","display":"Casalegno Garduño, Rosaely","family":"Casalegno Garduño","role":"aut"},{"role":"aut","family":"Schmitt","display":"Schmitt, Anita","given":"Anita"},{"role":"aut","family":"Spitschak","given":"Alf","display":"Spitschak, Alf"},{"role":"aut","family":"Greiner","given":"Jochen","display":"Greiner, Jochen"},{"family":"Wang","given":"Lei","display":"Wang, Lei","role":"aut"},{"role":"aut","family":"Hilgendorf","given":"Inken","display":"Hilgendorf, Inken"},{"role":"aut","family":"Hirt","display":"Hirt, Carsten","given":"Carsten"},{"role":"aut","given":"Anthony Dick","display":"Ho, Anthony Dick","family":"Ho"},{"role":"aut","family":"Freund","display":"Freund, Mathias","given":"Mathias"},{"role":"aut","family":"Schmitt","display":"Schmitt, Michael","given":"Michael"}],"language":["eng"],"title":[{"title":"Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation","title_sort":"Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation"}]} 
SRT |a CASALEGNOGIMMUNERESP2016